Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Americo

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of InoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Virology|May 18, 2007
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengePragati Nigam, Patricia L Earl, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Virology|May 15, 2007
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primatePatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Nature|March 12, 2004
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypoxPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Science Translational Medicine|October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challengeAlec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of InoculationCatherine A Cotter, Maxinne A Ignacio, Jeffrey L Americo, et al.
Virology|May 18, 2007
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challengePragati Nigam, Patricia L Earl, Jeffrey L Americo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virusPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Virology|May 15, 2007
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primatePatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Nature|March 12, 2004
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypoxPatricia L Earl, Jeffrey L Americo, Linda S Wyatt, et al.
Science Translational Medicine|October 4, 2023
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challengeAlec W Freyn, Caroline Atyeo, Patricia L Earl, et al.
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Pageof 4